Igene Biotechnology, Inc. Share Price

Equities

IGNE

US4516951005

Agricultural Chemicals

Market Closed - OTC Markets 12:50:08 22/03/2024 am IST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Igene Biotechnology, Inc. -.--% -.--%
Sales 2008 7.64 637.38 Sales 2009 3.96 330 Capitalization 15.6M 1.3B
Net income 2008 -3M -250M Net income 2009 - 0 EV / Sales 2008 -61,795 x
Net cash position 2008 1.13M 94.59M Net cash position 2009 931K 77.65M EV / Sales 2009 37,07,189 x
P/E ratio 2008
-0.28 x
P/E ratio 2009
-110 x
Employees -
Yield 2008 *
-
Yield 2009
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.00
More quotes
Managers TitleAgeSince
President 67 01/86/01
Members of the board TitleAgeSince
President 67 01/86/01
More insiders
IGENE Biotechnology, Inc. (Igene) is focused on the research, development, production and commercialization of specialty ingredients for human and animal nutrition. The Company develops, produces and markets specialty biochemical products. It is a supplier of natural astaxanthin, a nutrient in different feed applications and a source of pigment for coloring farmed salmon species. Igene provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors. It also provides analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. Within animal nutrition, the Company focus is to deliver astaxanthin to the fish feed market.
More about the company